Our facilities

To support stem cell research, MCRI has established state-of-the-art facilities including an iPSC Derivation and Gene Editing Facility which annually services internal and external researchers across the world.

MCRI has also recently established a Stem Cell Disease Modelling & Drug Screening Facility to provide high content screening capacity for 3D organoids, as well as the development of significant expertise in transcriptomics and bioinformatics.

Find out more: 

Proudly in partnership with

The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is supported by a Novo Nordisk Foundation grant number NNF21CC0073729​​